Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-12

Clinical Trial Update: Confirmatory Study of OPC-12759 Ophthalmic Suspension [Phase 3]

View source ↗

Summary

Phase 3 confirmatory study of OPC-12759 ophthalmic suspension for dry eye syndrome has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OPC-12759 (OPC-12759)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 3 | Status: COMPLETED | Results posted: 2013-12-12